当前位置:首页 - 行情中心 - 以岭药业(002603) - 财务分析 - 现金流量表

以岭药业

(002603)

  

流通市值:269.47亿  总市值:327.12亿
流通股本:13.76亿   总股本:16.71亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金1,936,876,740.929,181,144,274.417,428,415,814.716,002,088,865.43
收到的税费返还10,113,391.1884,495,426.175,942,180.9473,301,161.97
收到其他与经营活动有关的现金44,089,412.64277,806,667.31160,075,763.41127,199,608.45
经营活动现金流入的平衡项目0000
经营活动现金流入小计1,991,079,544.749,543,446,367.827,664,433,759.066,202,589,635.85
购买商品、接受劳务支付的现金605,700,912.483,417,237,812.382,668,618,252.491,835,088,574.9
支付给职工以及为职工支付的现金553,593,143.562,226,489,528.411,788,960,782.081,298,569,331.04
支付的各项税费326,959,319.881,408,189,360.511,279,559,078.861,111,576,558.01
支付其他与经营活动有关的现金387,820,896.862,336,072,232.731,782,673,047.281,276,817,323.68
经营活动现金流出的平衡项目0000
经营活动现金流出小计1,874,074,272.789,387,988,934.037,519,811,160.715,522,051,787.63
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额117,005,271.96155,457,433.79144,622,598.35680,537,848.22
二、投资活动产生的现金流量:
收回投资收到的现金1,467,775,784.743,687,223,373.282,991,000,0002,161,000,000
取得投资收益收到的现金13,352,628.9837,834,121.821,242,621.4221,332,277.61
处置固定资产、无形资产和其他长期资产收回的现金净额1,610.62965,959.83634,344.7278,497
投资活动现金流入的平衡项目0000
投资活动现金流入小计1,481,130,024.343,726,023,454.913,012,876,966.122,182,610,774.61
购建固定资产、无形资产和其他长期资产支付的现金62,825,146.61310,833,993.1208,484,043.53122,416,078.2
投资支付的现金1,341,000,0003,638,122,333.333,286,802,333.332,726,802,333.33
取得子公司及其他营业单位支付的现金-676,285,002.38628,877,661.14499,684,507.16
投资活动现金流出的平衡项目0000
投资活动现金流出小计1,403,825,146.614,625,241,328.814,124,164,0383,348,902,918.69
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额77,304,877.73-899,217,873.9-1,111,287,071.88-1,166,292,144.08
三、筹资活动产生的现金流量:
取得借款收到的现金400,000,0001,200,000,0001,100,000,000600,000,000
收到其他与筹资活动有关的现金80,526,733.33500,000,000198,416,229.17100,000,000
筹资活动现金流入平衡项目0000
筹资活动现金流入小计480,526,733.331,700,000,0001,298,416,229.17700,000,000
偿还债务支付的现金401,334,500650,300,000350,000,000150,000,000
分配股利、利润或偿付利息支付的现金7,892,170.98872,771,948.06405,481,535.5318,402,805.54
支付其他与筹资活动有关的现金1,278,434.21397,523,033.38395,755,392.51203,818,656.21
筹资活动现金流出平衡项目0000
筹资活动现金流出小计410,505,105.191,920,594,981.441,151,236,928.04372,221,461.75
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额70,021,628.14-220,594,981.44147,179,301.13327,778,538.25
四、汇率变动对现金及现金等价物的影响5,380.45326,399.88422,297.25541,431.6
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额264,337,158.28-964,029,021.67-819,062,875.15-157,434,326.01
加:期初现金及现金等价物余额846,634,129.481,810,663,151.151,810,663,151.151,810,663,151.15
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额1,110,971,287.76846,634,129.48991,600,2761,653,228,825.14
补充资料:
净利润-1,344,302,675.78-1,603,050,349.93
资产减值准备-59,056,297.11-18,652,890.34
固定资产和投资性房地产折旧-506,370,037.01-240,016,636.45
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-506,370,037.01-240,016,636.45
无形资产摊销-34,271,631.81-13,139,159.54
长期待摊费用摊销-947,212.02-409,772.68
处置固定资产、无形资产和其他长期资产的损失-819,304.68-951,694.81
固定资产报废损失-2,078,015.5--
公允价值变动损失--39,353,763.88--27,700,097.22
财务费用-38,900,732.82-15,798,081.28
投资损失--38,725,657.36--13,820,890.91
递延所得税-104,482,036.09-232,999,283.1
其中:递延所得税资产减少-100,847,801.67-115,906,202.4
递延所得税负债增加-3,634,234.42-117,093,080.7
存货的减少--459,668,361.78--490,536,519.33
经营性应收项目的减少--700,492,375.3--466,249,454.02
经营性应付项目的增加--722,762,581.37--449,693,365.6
其他-17,351,312.35--
现金的期末余额-846,634,129.48-1,653,228,825.14
减:现金的期初余额-1,810,663,151.15-1,810,663,151.15
公告日期2024-04-272024-04-272023-10-282023-08-29
审计意见(境内)标准无保留意见
TOP↑